HSA — authorised 22 December 2021
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
HSA authorised Leqvio on 22 December 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 22 December 2021.
NOVARTIS PHARMS CORP holds the Singaporean marketing authorisation.